Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder [NA]
A clinical trial is investigating intermittent theta burst stimulation (iTBS) as a way to improve emotion regulation in individuals with bip…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Open Label Extension Study of NCT06221852 [NA]
Open-label extension study NCT06221852 is currently enrolling by invitation. The sponsor is McLean Hospital and the study targets Bipolar I …
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Behavioural Activation for Bipolar Depression [NA]
A clinical trial at Reykjavik University is recruiting to evaluate behavioural activation as a treatment for bipolar depression.
-
FDA approval · 2025-04-15FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for lurasidone hydrochloride, enabling the generic to be marketed in the United…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders [Phase 2]
Phase 2 clinical trial evaluating the effects of intranasal insulin on neuroimaging markers and cognition in patients with psychotic disorde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-15FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for divalproex sodium.
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
An ongoing Mayo Clinic study recruiting participants to identify cerebral hemodynamic patterns in mood disorders and mild cognitive impairme…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) [Phase 4]
Phase 4 clinical trial evaluating ziprasidone for bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder; re…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder [NA]
This entry notes the completion of a clinical trial evaluating task-state-based temporal interference stimulation as a non-invasive method t…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept
A proof-of-concept clinical study exploring apathy-related neurobehavioral markers of cognitive decline in elderly individuals with bipolar …
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder [NA]
This clinical trial update indicates that a study assessing Acceptance and Commitment Therapy for depressive symptoms in Bipolar Disorder is…
-
FDA approval · 2025-04-02FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate submitted by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Metacognitive Training With Bipolar Disorder Patients. [NA]
This document provides an update on a clinical trial evaluating metacognitive training for patients with bipolar disorder. The study is curr…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: SYNCED - SYNChronized Eating in Bipolar Depression Study [NA]
A not-yet-recruiting clinical trial named SYNCED is investigating synchronized eating as an intervention for bipolar depression, including B…
-
FDA approval · 2025-03-27FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium (divalproex) by Aurobindo Pharma Limited. The approval pertains to the generic…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
Complete status update for a specified drug-use survey of Abilify Prolonged Release Aqueous Suspension for intramuscular injection in Bipola…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder [Phase 3]
Clinical trial update reports completion of a Phase 3 study evaluating lumateperone as monotherapy in bipolar depression and major depressiv…
-
FDA approval · 2025-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for ZIPRASIDONE HYDROCHLORIDE, a generic form of ziprasidone, indicating appro…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: A Compassionate-focused Intervention for Older People with Bipolar Disorder [NA]
A clinical trial sponsored by the University of Manchester is evaluating a compassionate-focused intervention for older adults with bipolar …
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
A clinical trial update indicates Psyrin Inc. is enrolling participants to test a speech-based machine learning algorithm that aims to predi…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning [NA]
A completed clinical trial evaluating the efficacy of a machine-learning-based mobile app to predict and prevent mood episode recurrence in …
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD) [Phase 1]
A Phase 1 study assessing the pharmacokinetics, safety, and tolerability of ABBV-932 in healthy volunteers and in individuals with generaliz…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients [Phase 3]
Phase 3 study evaluating Endoxifen for Bipolar I Disorder; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Cognitive Stimulation for Elderly Bipolar Patients [NA]
A clinical trial is currently recruiting to assess cognitive stimulation in elderly patients with bipolar disorder and cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]
A Phase 4 clinical trial assessing gamma-aminobutyric acid (GABA) function in psychosis has completed.